The seizures of around one-third of people with epilepsy are resistant to available medicines — a statistic that haunts neurology. It has been this way for decades. The medicines have got better by ...

Researchers identify early brain connectivity signals that may help predict treatment response after minimally invasive ...

A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

New POLARIS Phase I/II data presented at ASGCT show ETX101 gene therapy reducing seizures and improving neurodevelopment in ...

There are many different types of epileptic seizures, but all of them spur from batches of overactive neurons. While gene therapies have shown promise in treating epilepsy, most of those developed so ...

Neurona Therapeutics and UCSF researchers have developed and characterized a cell therapy alternative to treat drug-resistant mesial temporal lobe epilepsy (MTLE), the most common type of focal ...

The burden of Epilepsy care and management has gradually shifted from lack of knowledge and information to the gap in treatment. While Epilepsy is manageable and treatable, it requires a ...

A new form of gene therapy designed to treat the most treatment-resistant form of childhood epilepsy appears to reduce seizures in mice. In a research article published Dec. 14 in Brain, researchers ...

Research from the University of Virginia School of Medicine suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for ...

Something like 50 million people worldwide have epilepsy. While the majority of these people are able to use medications to manage and prevent their seizures, around one-third don’t respond well to ...

Neurosurgery One reports that new-onset seizures can signal brain tumors, prompting urgent investigation, with up to 50% of ...